The Retrospective Analysis of Clopidogrel Resistance Tests

Background: Clopidogrel binds to P2Y12 and inhibits platelet aggregation. Clopidogrel resistance can be categorized into two main categories: laboratory clopidogrel resistance and clinical clopidogrel resistance. Laboratory clopidogrel resistance refers to the inadequate in vitro antiplatelet effects of clopidogrel. In the present study, we aimed to evaluate the clopidogrel resistance test results from the perspective of laboratory specialists. Methods: All clopidogrel resistance test results from the Bilkent City Hospital laboratory information system, between February 1, 2019, and May 31, 2025, were collected. Clopidogrel resistance tests were performed using the adenosine diphosphate-induced platelet aggregation method using an aggreometer device (Stago Chrono-Log Model 700). Data were expressed as mean, minimum, and maximum levels, numerically and as percentages. The Chi-square test was performed a categorical data comparison between the created groups. IBM SPSS Statistics performed statistical analyses for Windows, Version 27.0 (IBM Corp., Armonk, NY, USA). Results: A total of 285 clopidogrel resistance test results were included. Negative and positive clopidogrel test results were as follows: 95 (33.3 %) and 190 (66.7 %). The present study consisted of 98 (34.4 %) females, 187 (65.6 %) males’ clopidogrel resistance tests. There were 107 (37.5 %) clopidogrel resistance test results in the under 65 years old group, while there were 178 (62.5 %) in the 65 and older years group. The neurology clinic requested clopidogrel resistance tests mostly (N:72, 62.5 %). No statistical differences were found in gender among age intervals (p>0.05), in clopidogrel resistance tests among gender (p>0.05), and in clopidogrel resistance tests among age intervals (p>0.05). Conclusion: The most appropriate laboratory test to assess clopidogrel resistance has not yet been determined. The present study, evaluated from a laboratory perspective, may be useful for future research; however, prospective studies combining laboratory and clinical findings may be more effective.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-11
DOI
https://doi.org/10.5281/zenodo.17419812
Primary Topic
Bioenergy crop production and management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Retrospective Analysis of Clopidogrel Resistance Tests

Zenodo (CERN European Organization for Nuclear Research)
Bioenergy crop production and management
article

The Retrospective Analysis of Clopidogrel Resistance Tests

article en

Abstract

Background: Clopidogrel binds to P2Y12 and inhibits platelet aggregation. Clopidogrel resistance can be categorized into two main categories: laboratory clopidogrel resistance and clinical clopidogrel resistance. Laboratory clopidogrel resistance refers to the inadequate in vitro antiplatelet effects of clopidogrel. In the present study, we aimed to evaluate the clopidogrel resistance test results from the perspective of laboratory specialists. Methods: All clopidogrel resistance test results from the Bilkent City Hospital laboratory information system, between February 1, 2019, and May 31, 2025, were collected. Clopidogrel resistance tests were performed using the adenosine diphosphate-induced platelet aggregation method using an aggreometer device (Stago Chrono-Log Model 700). Data were expressed as mean, minimum, and maximum levels, numerically and as percentages. The Chi-square test was performed a categorical data comparison between the created groups. IBM SPSS Statistics performed statistical analyses for Windows, Version 27.0 (IBM Corp., Armonk, NY, USA). Results: A total of 285 clopidogrel resistance test results were included. Negative and positive clopidogrel test results were as follows: 95 (33.3 %) and 190 (66.7 %). The present study consisted of 98 (34.4 %) females, 187 (65.6 %) males’ clopidogrel resistance tests. There were 107 (37.5 %) clopidogrel resistance test results in the under 65 years old group, while there were 178 (62.5 %) in the 65 and older years group. The neurology clinic requested clopidogrel resistance tests mostly (N:72, 62.5 %). No statistical differences were found in gender among age intervals (p>0.05), in clopidogrel resistance tests among gender (p>0.05), and in clopidogrel resistance tests among age intervals (p>0.05). Conclusion: The most appropriate laboratory test to assess clopidogrel resistance has not yet been determined. The present study, evaluated from a laboratory perspective, may be useful for future research; however, prospective studies combining laboratory and clinical findings may be more effective.

Zenodo (CERN European Organization for Nuclear Research)
University of Health Science (KH), Başkent University Hospital (TR), Sağlık Bilimleri Üniversitesi (TR), University of Health Sciences Antigua (AG)
Openalex Percentile: Top 37%
Bioenergy crop production and management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.